Loading
Total declarations
Companies
▲ Purchases (48 ops.)
▼ Sales (12 ops.)
Latest filing published 18 Sept 2025 for Y-mAbs Therapeutics, Inc..
Filing timeline
BuySaleJames Healy
Insider track record
Disclosed buys
48
Disclosed sells
12
Signal history
Closed purchases
Market purchases
48
Positive at T+90
8%
Median T+90
-22.1%
Based on 25 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -73.8%Entry US$20.80 · Close at T+365 US$5.45
- -49.7%Entry US$23.93 · Close at T+365 US$12.04
- -42.0%Entry US$20.85 · Close at T+365 US$12.10
- +29.8%Entry US$21.98 · Close at T+365 US$28.54
- -56.8%Entry US$108.96 · Close at T+365 US$47.03
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
James Healy: trading record in brief
James Healy is above all a buyer: 47 purchases, 45 of them with an amount worth EUR 87,275,564 (median EUR 295,561), 80% of the market trades. The largest are dated November 25, 2019 (EUR 13,608,450) and July 2, 2019 (EUR 9,917,600) at Karuna Therapeutics, then September 27, 2024 at BioAge Labs, Inc. (EUR 9,483,594). The 12 sales, 7 of them with an amount worth EUR 42,547,650, include EUR 35,036,722 at Natera, Inc. on December 13, 2023, far ahead of EUR 3,974,921 at Coherus Oncology, Inc. on September 29, 2021.
A Director, James Healy has 120 filings from March 15, 2016 to September 18, 2025, at Karuna Therapeutics (29), Natera (23), Rapport Therapeutics (18), Coherus Oncology (15) and Y-mAbs Therapeutics, Inc. (10). Stored results, not a forecast: across 25 purchases with a 90-day result, the median is minus 22.1%, and 8% are positive.
The peak is 2024 with 37 filings. No filing falls in the last twelve months. Heather Preston has 6 trades close to trades by James Healy, in the same direction.
Companies and markets linked to James Healy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations120 total
25,080 sharesCommon StockSEC:0001245624-25-000004:1
2,194,278 shares@ US$8.6062.3% of flowCommon StockSEC:0001245624-25-000004:2
31,603 shares@ US$8.60100.0% of flowCommon StockSEC:0001245624-25-000004:0
25,080 shares0Common StockSEC:0001415889-25-019047:0
142 sharesCommon StockSEC:0001415889-25-011552:0
114 sharesCommon StockSEC:0001415889-25-003070:0
153 sharesCommon StockSEC:0001415889-24-025715:0
588,888 shares@ US$18.0088.3% of flowCommon StockSEC:0001415889-24-024044:1
Canonical exit: 26 Dec 2024 (T+90)
11,113 shares@ US$18.001.7% of flowCommon StockSEC:0001415889-24-024044:2
Canonical exit: 26 Dec 2024 (T+90)
18,353 shares@ US$18.002.8% of flowCommon StockSEC:0001415889-24-024044:3
Canonical exit: 26 Dec 2024 (T+90)
21,814 shares@ US$18.003.3% of flowCommon StockSEC:0001415889-24-024044:4
Canonical exit: 26 Dec 2024 (T+90)
26,497 shares@ US$18.004.0% of flowCommon StockSEC:0001415889-24-024044:5
Canonical exit: 26 Dec 2024 (T+90)
1,638,236 sharesCommon StockSEC:0001415889-24-024044:0
177 sharesCommon StockSEC:0001415889-24-020384:0
4,878 shares@ US$25.021.2% of flowCommon StockSEC:0001104659-24-077868:6
Canonical exit: 29 Sept 2024 (T+90)
2,748 shares@ US$26.060.7% of flowCommon StockSEC:0001104659-24-077868:7
Canonical exit: 29 Sept 2024 (T+90)
3,565 shares@ US$24.210.8% of flowCommon StockSEC:0001104659-24-077868:1
Canonical exit: 29 Sept 2024 (T+90)
4,544 shares@ US$25.021.1% of flowCommon StockSEC:0001104659-24-077868:2
Canonical exit: 29 Sept 2024 (T+90)
2,559 shares@ US$26.060.6% of flowCommon StockSEC:0001104659-24-077868:3
Canonical exit: 29 Sept 2024 (T+90)
3,799 shares@ US$23.080.8% of flowCommon StockSEC:0001104659-24-077868:4
Canonical exit: 29 Sept 2024 (T+90)
3,828 shares@ US$24.210.9% of flowCommon StockSEC:0001104659-24-077868:5
Canonical exit: 29 Sept 2024 (T+90)
3,630 shares@ US$23.080.8% of flowCommon StockSEC:0001104659-24-077868:8
Canonical exit: 29 Sept 2024 (T+90)
3,657 shares@ US$24.210.8% of flowCommon StockSEC:0001104659-24-077868:9
Canonical exit: 29 Sept 2024 (T+90)
4,661 shares@ US$25.021.1% of flowCommon StockSEC:0001104659-24-077868:10
Canonical exit: 29 Sept 2024 (T+90)
2,625 shares@ US$26.060.6% of flowCommon StockSEC:0001104659-24-077868:11
Canonical exit: 29 Sept 2024 (T+90)
25 of 120 declarations
